Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19
This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.